Follistim (TM) (follitropin beta for injection)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved September 1997

Specific Treatments:

infertility

Find Related Trials for The Following Conditions

General Information

The U.S. Food and Drug Administration approved Oregonon's Follistim (TM) (follitropin beta for injection), the first recombinant follicle-stimulating hormone available in the U.S. for the treatment of infertility. Follistim works by stimulating ovaries to produce one or more eggs during each treatment.